Sample Alert 2

Biotech Insight Alert 5/31/2017 Biotech has been beaten down as money has rotated out of the small-cap biotech sector. There are a number of reasons for this mostly political with probable pricing pressure and now a Supreme Court decision that could impact pricing if products are allowed to be re-imported. I think both of theseContinue reading

Sample Alert 1

Biotech Insight Alert 10/21/2016 Small-cap biotechs continue to tread water down near their lows with some upside in a few companies.  If Clinton wins the presidency, as seems likely, there will be major implications for big pharma and some smaller companies—that is also assuming as least the Senate turns as well. I expect generics toContinue reading